eleganC Bio
Athens, United States (US) · Health and Medical
Do your work at eleganC Bio?
Claim this profile to manage your company.
Verified by Enterprise League
Data quality
Complete · Accuracy
Last verified
May 2026
#neuroprotection & cognitive longevity
#cardiovascular & metabolic vitality
#"molecule-to-mechanism" structural elucidation
#asset-light research operations (ros)
Overview
We bridge the ‘validation gap’ in the botanical industry by merging high-fidelity analytical chemistry with biological screening. Utilizing an asset-light model within a Tier-1 research ecosystem, we transform raw extracts into high-value, licensable data packages and proprietary Technical Dossiers.
Our ‘Molecule-to-Mechanism’ Pathway establishes a rigorous scientific foundation through a dual-track validation pathway. We integrate high-resolution HPLC and 1D/2D NMR spectroscopy with high-throughput functional screening to establish a clear Mode of Action (MoA) for every ingredient. By providing comprehensive Biological Characterization, we produce the reproducible data required to support credibility and regulatory alignment.
EleganC Bio converts scientific milestones into commercial advantage by aligning molecular validation with strategic asset profiling. We de-risk the innovation process through documented Mechanistic Substantiation, providing a structured pathway for long-term product success and leadership in highly competitive botanical categories.
Contact Details
Athens, United States (US), 111 Riverbend Rd
+1
Founded
2025
Company Type
Private Limited Company
Employees
2-10
Categories
Keywords
#neuroprotection & cognitive longevity
#cardiovascular & metabolic vitality
#"molecule-to-mechanism" structural elucidation
#asset-light research operations (ros)
Listings
Companies teams usually look at after eleganC Bio
Comparing a few options usually leads to better decisions
Save companies to compare later. Useful when sharing options with your team
This is how your company profile looks to others.

